Register is pretty tight mate, probably as tight as its been ever.
The more shares end up in the hands of Canary and their HNW client base the better. More vol churned at these levels also the better, the real re-rate hasn't come yet.... will make the moves easier and faster if more vol gets churned into sticky hands at these levels rather than at 20-30c+.
- Forums
- ASX - By Stock
- IHL
- Ann: Positive IHL-675A in vivo results and FDA Pathway
Ann: Positive IHL-675A in vivo results and FDA Pathway, page-111
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online